Welcome to our dedicated page for Yield10 Bioscience news (Ticker: $YTEN), a resource for investors and traders seeking the latest updates and insights on Yield10 Bioscience stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Yield10 Bioscience's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Yield10 Bioscience's position in the market.
Rhea-AI Summary
Yield10 Bioscience (YTEN) achieves a significant milestone in the development of Camelina for biofuels and Omega-3 oils. The USDA-APHIS has cleared glufosinate tolerant Camelina for growth and breeding in the U.S., driving commercial launch as early as 2025. Yield10's approach to developing elite Camelina varieties aims to benefit growers, offering new options for weed management and sustainable agriculture solutions. The company is building seed inventory to support commercial launch and expand its portfolio of commercial Camelina varieties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.13%
Tags
-
Rhea-AI Summary
Yield10 Bioscience, Inc. (Nasdaq:YTEN) - Camelina Seed Genetics to Biofuel Platform Established, Herbicide Tolerant Camelina Varieties Advancing, and Exclusive Global License for Advanced Omega-3 Technology Finalized
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.13%
Tags
-
Rhea-AI Summary
Yield10 Bioscience, Inc. (Nasdaq:YTEN) will report Q3 2023 financial results and provide a corporate update on November 14, 2023. A conference call will be hosted to review financial results, corporate highlights, and business update. Interested parties can listen to the call via phone or webcast, with a replay available through November 28, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.71%
Tags
Rhea-AI Summary
Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA equal to fish oil. This Omega-3 Camelina technology has the potential to become an important supplement to the scarce supply of marine long-chain fatty acids. Yield10 expects to scale-up planted acres of Camelina to supply BioMar with oil for formulation and testing while also working towards securing regulatory approval for commercial production of Omega-3 Camelina oil and meal.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.45%
Tags
-
Rhea-AI Summary
Sono-Tek Corporation to present at the Fall Foliage MicroCap Rodeo Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
-
Rhea-AI Summary
Yield10 Bioscience exercises option to finalize exclusive global license for omega-3 production technology from Rothamsted Research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.13%
Tags
Rhea-AI Summary
Yield10 Bioscience announces advancements in herbicide tolerant Camelina for biofuel market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.15%
Tags
-
Rhea-AI Summary
Yield10 Bioscience begins revenue generation for its 'Camelina Seed Genetics to Biofuel' platform as the harvest of Camelina grain is completed and delivered to an offtake partner for biofuel production. Revenue from Camelina grain sales expected to be a key contributor to the company's financial profile. Focus now on building technology foundation to accelerate grower adoption of Camelina for the biofuels market. Positive feedback from growers and plans to secure grower contracts for harvest in Q3 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
-
Rhea-AI Summary
Yield10 Bioscience to participate in H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
Rhea-AI Summary
Yield10 Bioscience, Inc. has closed its public offering of 5,750,000 units at a price of $0.65 per unit, resulting in gross proceeds of approximately $3.7 million. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The warrants are exercisable at $0.65 per share and expire in five years. Maxim Group LLC and Lake Street Capital Markets, LLC acted as joint placement agents for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Yield10 Bioscience, Inc.
Nasdaq:YTEN
YTEN Rankings
YTEN Stock Data
3.53M
14.21M
12.61%
3.97%
6.11%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
United States of America
WOBURN
About YTEN
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.